Apatinib, a small-molecule inhibitor of vascular endothelial growth factor receptor 2, has demonstrated encouraging anti-cancer activity in gastric cancer within both in vitro and in vivo models. AREAS COVERED: Apatinib's efficacy, tolerability and safety have been evaluated in one Phase II and one Phase III study in metastatic/advanced gastric cancer. In this review, we focus on the mechanism of action of apatinib, its pharmacokinetic profile and its clinical activity in the treatment of advanced/metastatic gastric cancer. Expert commentary: Unfortunately, as yet, there is no definitive biomarker data for apatinib in gastric cancer

Apatinib for the treatment of gastric cancer / Roviello Giandomenico; Ravelli Andrea; Fiaschi Anna Ida; Cappelletti Maria Rosa; Gobbi Angela; Senti Chiara; Zanotti Laura; Polom Karol; Reynolds Andrew R.; Fox Stephen B.; Generali Daniele. - In: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. - ISSN 1747-4124. - 10:(2016), pp. 887-892. [10.1080/17474124.2016.1209407]

Apatinib for the treatment of gastric cancer

Roviello Giandomenico;
2016

Abstract

Apatinib, a small-molecule inhibitor of vascular endothelial growth factor receptor 2, has demonstrated encouraging anti-cancer activity in gastric cancer within both in vitro and in vivo models. AREAS COVERED: Apatinib's efficacy, tolerability and safety have been evaluated in one Phase II and one Phase III study in metastatic/advanced gastric cancer. In this review, we focus on the mechanism of action of apatinib, its pharmacokinetic profile and its clinical activity in the treatment of advanced/metastatic gastric cancer. Expert commentary: Unfortunately, as yet, there is no definitive biomarker data for apatinib in gastric cancer
2016
10
887
892
Roviello Giandomenico; Ravelli Andrea; Fiaschi Anna Ida; Cappelletti Maria Rosa; Gobbi Angela; Senti Chiara; Zanotti Laura; Polom Karol; Reynolds Andrew R.; Fox Stephen B.; Generali Daniele
File in questo prodotto:
File Dimensione Formato  
Roviello G et al., 2016 Apatinib.pdf

Accesso chiuso

Dimensione 722.86 kB
Formato Adobe PDF
722.86 kB Adobe PDF   Richiedi una copia
Apatinib for the treatment of gastric cancer.pdf

Accesso chiuso

Dimensione 929.37 kB
Formato Adobe PDF
929.37 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1156835
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 71
  • ???jsp.display-item.citation.isi??? 67
social impact